The 2009 influenza A(H1N1) pandemic was declared over in August 2010 by the World Health Organization. Europe has now entered a new inter-pandemic phase of seasonal influenza.
WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
ECDC comment-
News
Update on narcolepsy cases associated with Pandemrix vaccination in 2009 in the Netherlands
ECDC comment-
News
No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix™ Vaccination Campaign in Finland
ECDC comment-
News
New Swedish Registry study confirms increased risk of narcolepsy in children and adolescents after vaccination with Pandemrix
ECDC comment-
News
Association of receipt of Pandemrix™ and narcolepsy in children and adolescents in the UK (England)
WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
ECDC comment-
News
Update on narcolepsy cases associated with Pandemrix vaccination in 2009 in the Netherlands
ECDC comment-
News
No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix™ Vaccination Campaign in Finland
ECDC comment-
News
New Swedish Registry study confirms increased risk of narcolepsy in children and adolescents after vaccination with Pandemrix
ECDC comment-
News
Association of receipt of Pandemrix™ and narcolepsy in children and adolescents in the UK (England)
Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines
23 Oct 2015
Geneva, Switzerland
Event
Training workshop on vaccine safety for Member States, building on the experience obtained in the ECDC vaccine safety project VAESCOArchived
23 Feb 2012 - 24 Feb 2012
Stockholm, Sweden
Publication
Guide to revision of national pandemic influenza preparedness plans: Lessons learned from the 2009 A(H1N1) pandemic
Technical report-
Peer-Reviewed Publication
Decreased effectiveness of the influenza A(H1N1) pdm09 strain in live attenuated influenza vaccines: An observational bias or a technical challenge?
Jan 2016
Peer-Reviewed Publication
Predominance of influenza A(H1N1)pdm09 virus genetic subclade 6B.1 and influenza B/Victoria lineage viruses at the start of the 2015/16 influenza season in Europe
Jan 2016
Peer-Reviewed Publication
Where are we in our understanding of the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines?
Jan 2016
Peer-Reviewed Publication
Assessment of human influenza pandemic scenarios in Europe
